Revenue declined 5.8% year-over-year to US$3.22 billion, with a net loss of US$319.4 million, but a US$1.42 billion capital injection in December 2025 restored positive equity and improved liquidity. Management expects continued operational and financial strengthening in 2026.
Original document:
This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.